loading control gapdh (Cell Signaling Technology Inc)
Structured Review

Loading Control Gapdh, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 12338 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/loading+control+gapdh/GAPDH+Rabbit+mAb/pmc12953323-58-45-48
Average 99 stars, based on 12338 article reviews
Images
1) Product Images from "Autophagy hub genes mediate photodynamic therapy tolerance in nasopharyngeal carcinoma through cytoprotective autophagy and survival signaling"
Article Title: Autophagy hub genes mediate photodynamic therapy tolerance in nasopharyngeal carcinoma through cytoprotective autophagy and survival signaling
Journal: Journal of Molecular Histology
doi: 10.1007/s10735-026-10746-x
Figure Legend Snippet: PDT induces autophagic flux in nasopharyngeal carcinoma cells. A This panel shows representative western blots of LC3-II, p62/SQSTM1, and GAPDH in C666-1 and HONE1 cells, respectively, treated with PDT alone or in combination with rapamycin (autophagy activation) or chloroquine (autophagy inhibition). B This panel shows densitometric quantification of LC3-II and p62 normalized to GAPDH, respectively, presented as mean ± SD from independent experiments performed separately in each cell line. P ***-value < 0.001
Techniques Used: Western Blot, Activation Assay, Inhibition
Related Articles
Electrophoresis:Article Title: Berberine attenuates cigarette smoke extract-induced stress and senescence-associated changes in human brain microvascular endothelial cells. Article Snippet: 13 Objective: The aim of this study is to investigate the protective effects of berberine 14 (BBR) against cigarette smoke extract (CSE)-induced injury in human brain 15 microvascular endothelial cells and to identify candidate molecules and associated 16 candidate molecules.. 17 Methods: hCMEC/D3 cells were exposed to 4% CSE and/or 7.5 μM BBR for 24 h. 18 Inflammation, oxidative stress, and senescence-associated phenotypes were assessed.. 19 Previously generated CSE-responsive transcriptomic data were integrated with 20 ChEMBL-derived candidates, followed by enrichment, weighted prioritization, protein– 21 protein interaction (PPI) analysis, and docking. SDS Page:Article Title: Berberine attenuates cigarette smoke extract-induced stress and senescence-associated changes in human brain microvascular endothelial cells. Article Snippet: 13 Objective: The aim of this study is to investigate the protective effects of berberine 14 (BBR) against cigarette smoke extract (CSE)-induced injury in human brain 15 microvascular endothelial cells and to identify candidate molecules and associated 16 candidate molecules.. 17 Methods: hCMEC/D3 cells were exposed to 4% CSE and/or 7.5 μM BBR for 24 h. 18 Inflammation, oxidative stress, and senescence-associated phenotypes were assessed.. 19 Previously generated CSE-responsive transcriptomic data were integrated with 20 ChEMBL-derived candidates, followed by enrichment, weighted prioritization, protein– 21 protein interaction (PPI) analysis, and docking. Blocking Assay:Article Title: Berberine attenuates cigarette smoke extract-induced stress and senescence-associated changes in human brain microvascular endothelial cells. Article Snippet: 13 Objective: The aim of this study is to investigate the protective effects of berberine 14 (BBR) against cigarette smoke extract (CSE)-induced injury in human brain 15 microvascular endothelial cells and to identify candidate molecules and associated 16 candidate molecules.. 17 Methods: hCMEC/D3 cells were exposed to 4% CSE and/or 7.5 μM BBR for 24 h. 18 Inflammation, oxidative stress, and senescence-associated phenotypes were assessed.. 19 Previously generated CSE-responsive transcriptomic data were integrated with 20 ChEMBL-derived candidates, followed by enrichment, weighted prioritization, protein– 21 protein interaction (PPI) analysis, and docking. Incubation:Article Title: Berberine attenuates cigarette smoke extract-induced stress and senescence-associated changes in human brain microvascular endothelial cells. Article Snippet: 13 Objective: The aim of this study is to investigate the protective effects of berberine 14 (BBR) against cigarette smoke extract (CSE)-induced injury in human brain 15 microvascular endothelial cells and to identify candidate molecules and associated 16 candidate molecules.. 17 Methods: hCMEC/D3 cells were exposed to 4% CSE and/or 7.5 μM BBR for 24 h. 18 Inflammation, oxidative stress, and senescence-associated phenotypes were assessed.. 19 Previously generated CSE-responsive transcriptomic data were integrated with 20 ChEMBL-derived candidates, followed by enrichment, weighted prioritization, protein– 21 protein interaction (PPI) analysis, and docking. Article Title: METTL14-mediated m 6 A methylation orchestrates early NK cell development by maintaining metabolic fitness. Article Snippet: Protein samples from the lysed NK cells were separated by SDSPAGE and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore) via wet transfer (Bio-Rad, USA). .. Membranes were blocked with 5% non-fat milk and incubated overnight at 4°C with the Article Title: MiR-221 Overexpression Alters Cell-Cycle Distribution and Reduces Myogenic Gene Expression in C2C12 Myoblasts Article Snippet: .. The membrane was blocked with 10% non-fat dry milk at room temperature for 2 h. It was then incubated with anti-p27 antibody (1:2000, 2552S, CST, Danvers, MA, USA) at 4 °C overnight, or with Cell-Signaling:Article Title: Berberine attenuates cigarette smoke extract-induced stress and senescence-associated changes in human brain microvascular endothelial cells. Article Snippet: 13 Objective: The aim of this study is to investigate the protective effects of berberine 14 (BBR) against cigarette smoke extract (CSE)-induced injury in human brain 15 microvascular endothelial cells and to identify candidate molecules and associated 16 candidate molecules.. 17 Methods: hCMEC/D3 cells were exposed to 4% CSE and/or 7.5 μM BBR for 24 h. 18 Inflammation, oxidative stress, and senescence-associated phenotypes were assessed.. 19 Previously generated CSE-responsive transcriptomic data were integrated with 20 ChEMBL-derived candidates, followed by enrichment, weighted prioritization, protein– 21 protein interaction (PPI) analysis, and docking. Article Title: Licoflavone B mitigates allergic rhinitis by restraining epithelial PI3K-AKT/NF-κB NLRP3 inflammasome signaling. Article Snippet: Licoflavone B (LFB; analytical grade, ≥98%; MedChemExpress, Cat. HY-N4184) was prepared per vendor instructions; poly(I:C) HMW (InvivoGen, Cat. tlrl-pic) served as the TLR3 agonist; recombinant human IGF-1 (PeproTech, Cat. 100–11) was reconstituted immediately before use. .. For immunoblotting, the following primary antibodies were used: NLRP3 (Cell Signaling Technology, #15,101), ASC/TMS1 (CST, #13,833), caspase−1 (CST, #2225), IL-1β—mouse specific (CST, #8689), phospho-PI3K p85 (Tyr458)/p55 (Tyr199) (CST, #4228), total PI3K p85 (CST, #4292), phospho-AKT (Ser473) (CST, #4060), total AKT (pan) (CST, #4691), phospho-NF-κB p65 (Ser536) (CST, #3033), total NF-κB p65 (CST, #8242), and Membrane:Article Title: MiR-221 Overexpression Alters Cell-Cycle Distribution and Reduces Myogenic Gene Expression in C2C12 Myoblasts Article Snippet: .. The membrane was blocked with 10% non-fat dry milk at room temperature for 2 h. It was then incubated with anti-p27 antibody (1:2000, 2552S, CST, Danvers, MA, USA) at 4 °C overnight, or with Expressing:Article Title: MiR-221 Overexpression Alters Cell-Cycle Distribution and Reduces Myogenic Gene Expression in C2C12 Myoblasts Article Snippet: .. The membrane was blocked with 10% non-fat dry milk at room temperature for 2 h. It was then incubated with anti-p27 antibody (1:2000, 2552S, CST, Danvers, MA, USA) at 4 °C overnight, or with Western Blot:Article Title: Licoflavone B mitigates allergic rhinitis by restraining epithelial PI3K-AKT/NF-κB NLRP3 inflammasome signaling. Article Snippet: Licoflavone B (LFB; analytical grade, ≥98%; MedChemExpress, Cat. HY-N4184) was prepared per vendor instructions; poly(I:C) HMW (InvivoGen, Cat. tlrl-pic) served as the TLR3 agonist; recombinant human IGF-1 (PeproTech, Cat. 100–11) was reconstituted immediately before use. .. For immunoblotting, the following primary antibodies were used: NLRP3 (Cell Signaling Technology, #15,101), ASC/TMS1 (CST, #13,833), caspase−1 (CST, #2225), IL-1β—mouse specific (CST, #8689), phospho-PI3K p85 (Tyr458)/p55 (Tyr199) (CST, #4228), total PI3K p85 (CST, #4292), phospho-AKT (Ser473) (CST, #4060), total AKT (pan) (CST, #4691), phospho-NF-κB p65 (Ser536) (CST, #3033), total NF-κB p65 (CST, #8242), and other:Article Title: Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism. Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Clinical data Dual use research of concern Plants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used T cell cultures: Anti-CD3, OKT3, Thermo Scientific MA110175 Anti CD28, CD28.2, Biolegend 302943 Flow cytometry: All dilutions used were according to manufacturer’s instructions TruStain FcX (anti-mouse CD16/32) Antibody, BioLegend, Cat. #101320 Human TruStain FcX (Fc receptor blocking solution), Biolegend, Cat. # 422302 Anti-human CD14, 63D3, FITC, Biolegend 367116 Anti-human CD45, HI30, BV421 Biolegend 304032 Anti-human CD4, OKT4, BV510 Biolegend 317444 Anti-human CD19, HIB19, BV510 Biolegend 302242 Anti-human CD56 BV605 Biolegend 362538 Anti-human CD8a, RPA-T8, BV711 Biolegend 301044 Anti-Human HLA-DR, L243, BUV395 BD Biosciences 568648 Anti-Human CD3e, OKT3, PE/Dazzle594 Biolegend 317346 Anti-phospho-STAT3 (pY705) AF647 BD Biosciences 562071 Anti-phospho-STAT1 (pY701) PE, BD Biosciences 562069 Anti-Human Granzyme B, QA16A02 Biolegend 372204 Antibodies for Figure 4g eBioscience Fixable Viability Dye eFluor 780, Invitrogen, Cat. #65-0865-14 anti-CD45, HI30, BV421, Biolegend, 304032 HLA-DR, L234, BUV395, BD, 568647 CD19, HIB19, BV510, Biolegend, 302242 CD4, OKT4, BV510, Biolegend, 317444 CD8a, RPA-T8, BV711, Biolegend, 301044 CD56, 5.1H11, BV605, Biolegend, 362538 CD3, OKT3, PE/Dazzle 594, Biolegend, 317346 CD14, 63D3, FITC, Biolegend, 367116 CD1c, L161, APC, Biolegend, 331524 IL-10Ra, 3F9, PE, Biolegend, 308804 IL-10Rb, S17009F, PE/Cy7, Biolegend, 396808 Rat IgG2a, RTK2758, PE, Biolegend, 400508 Mouse IgG2a, MOPC-173, PE/Cy7, Biolegend, 400254 Antibodies for Figure 5a Anti-human CD14, MφP9, BV421, BD Biosciences 563743 Anti-human CD1a, HI149, PE/Dazzle594, Biolegend 300132 LIVE/DEAD Fixable Aqua Dead Cell Stain Kit, Thermo Fisher Scientific L34957 CD19, HIB19, APC/Cy7, BioLegend, 302218 CD27, O323,PE, BioLegend, 302808 CD38, HIT2, PE/Cy7, BioLegend, 303516 Antibodies for Figure 5c 4 nature portfolio | reporting sum m ary April 2023 Anti-human CD3, UCHT1, PerCP/Cyanine5.5, Biolegend 300430 Anti-human CD4, RPA-T4, PE/Dazzle594, Biolegend 300548 Influenza A HA307-319 Tetramer (PKYVKQNTLKLAT), DRB1*04:01, PE and APC Proimmune 357B SYTOX Blue Dead Cell Stain, Thermo Fisher Scientific S34857 Antibodies for Figure 5g and 5k Anti-mouse CD45, 30-F11, APC/Cy7, BD Biosciences 557659 Anti-mouse TCRβ, H57-597, BUV805, BD Biosciences 748405 Anti-mouse B220, RA3-6B2, PerCP/Cyanine5.5, BD Biosciences 552771 Anti-mouse CD11b, M1/70, BV421, BD Biosciences 562605 Anti-mouse Ly6G, 1A8, Alexa Fluor 700, Biolegend 127622 LIVE/DEAD Fixable Aqua Dead Cell Stain Kit, Thermo Fisher L34957 Western Blot: Anti-phospho TYK2 (pY1054/1055), D7T8A, Cell Singlaling Technology (CST) 68790 Anti-phopspho JAK1(pY1034/1035), polyclonal, CST 3331S Anti-TYK2, EPR24628-106, Abcam AB303400 Anti-JAK1, polyclonal, Ubiquitin Proteomics:Article Title: Weightlifting outperforms voluntary wheel running for improving adiposity and insulin sensitivity in obese mice Article Snippet: .. Primary antibodies used for analysis were from Cell Signaling Technologies (Danvers, MA, USA) and diluted 1:1000 unless otherwise stated as follows: protein kinase B (Akt; 1:500; #4691; Cell Signaling Technologies), phospho-Akt (pAkt) S473 (1:500; #9271; Cell Signaling Technologies), Ubiquitin (#3933; Cell Signaling Technologies), microtubule-associated protein light chain 3 (LC3 II/I; #4018; Cell Signaling Technologies), cytochrome c oxidase subunit 4(COX4; #11967; Cell Signaling Technologies), Akt substrate 160 (AS160 S318; #8619; Cell Signaling Technologies), AS160 T642 (#8881; Cell Signaling Technologies), eukaryotic translation initiation factor 4E binding protein (4E-BP1; #9452; Cell Signaling Technologies), and Binding Assay:Article Title: Weightlifting outperforms voluntary wheel running for improving adiposity and insulin sensitivity in obese mice Article Snippet: .. Primary antibodies used for analysis were from Cell Signaling Technologies (Danvers, MA, USA) and diluted 1:1000 unless otherwise stated as follows: protein kinase B (Akt; 1:500; #4691; Cell Signaling Technologies), phospho-Akt (pAkt) S473 (1:500; #9271; Cell Signaling Technologies), Ubiquitin (#3933; Cell Signaling Technologies), microtubule-associated protein light chain 3 (LC3 II/I; #4018; Cell Signaling Technologies), cytochrome c oxidase subunit 4(COX4; #11967; Cell Signaling Technologies), Akt substrate 160 (AS160 S318; #8619; Cell Signaling Technologies), AS160 T642 (#8881; Cell Signaling Technologies), eukaryotic translation initiation factor 4E binding protein (4E-BP1; #9452; Cell Signaling Technologies), and |

